SAHHCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。SAHH遺伝子サイレンサーは、SAHH CRISPR/Cas9ノックアウトプラスミドとSAHHDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のSAHHCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
SAHH CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
SAHH CRISPR/Cas9 KOプラスミド (h) | sc-402617 | h | Gene Knockout | GFP | 0 | ||
SAHH HDRプラスミド (h) | sc-402617-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
SAHH Double Nickaseプラスミド (h) | sc-402617-NIC | h | Gene Knockout | Puromycin | 0 | ||
SAHH Double Nickaseプラスミド (h2) | sc-402617-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
SAHH CRISPR/Cas9 KOプラスミド (m) | sc-435335 | m | Gene Knockout | GFP | 0 | ||
SAHH HDRプラスミド (m) | sc-435335-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
SAHH Double Nickaseプラスミド (m) | sc-435335-NIC | m | Gene Knockout | Puromycin | 0 | ||
SAHH Double Nickaseプラスミド (m2) | sc-435335-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
SAHH-3 CRISPR/Cas9 KOプラスミド (h) | sc-409847 | h | Gene Knockout | GFP | 0 | ||
SAHH-3 HDRプラスミド (h) | sc-409847-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
SAHH-3 Double Nickaseプラスミド (h) | sc-409847-NIC | h | Gene Knockout | Puromycin | 0 | ||
SAHH-3 Double Nickaseプラスミド (h2) | sc-409847-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
SAHH-3 CRISPR/Cas9 KOプラスミド (m) | sc-428844 | m | Gene Knockout | GFP | 0 | ||
SAHH-3 HDRプラスミド (m) | sc-428844-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
SAHH-3 Double Nickaseプラスミド (m) | sc-428844-NIC | m | Gene Knockout | Puromycin | 0 | ||
SAHH-3 Double Nickaseプラスミド (m2) | sc-428844-NIC-2 | m | Gene Knockout | Puromycin | 0 |
SAHH CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
SAHH CRISPR Activationプラスミド (h) | sc-402617-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
SAHH CRISPR Activationプラスミド (h2) | sc-402617-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
SAHH Lentiviral Activation Particles (h) | sc-402617-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
SAHH Lentiviral Activation Particles (h2) | sc-402617-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
SAHH CRISPR Activationプラスミド (m) | sc-435335-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
SAHH CRISPR Activationプラスミド (m2) | sc-435335-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
SAHH Lentiviral Activation Particles (m) | sc-435335-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
SAHH Lentiviral Activation Particles (m2) | sc-435335-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
SAHH-3 CRISPR Activationプラスミド (h) | sc-409847-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
SAHH-3 CRISPR Activationプラスミド (h2) | sc-409847-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
SAHH-3 Lentiviral Activation Particles (h) | sc-409847-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
SAHH-3 Lentiviral Activation Particles (h2) | sc-409847-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
SAHH-3 CRISPR Activationプラスミド (m) | sc-428844-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
SAHH-3 CRISPR Activationプラスミド (m2) | sc-428844-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
SAHH-3 Lentiviral Activation Particles (m) | sc-428844-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
SAHH-3 Lentiviral Activation Particles (m2) | sc-428844-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |